Showing results (1-10 of 9,782) with videos related to
Sort By:
Pageof 979
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|February 28, 2002
[A study on factors contributing to intelligence in 857 children]P Chen, F ChenClinical and Experimental Dermatology|October 4, 2018
Systematic review and meta-analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanomaP Chen, F Chen, B ZhouZhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|May 21, 2019
[Clinicopathological features and molecular genetics of paediatric-type follicular lymphoma: report of eight cases]F F Chen, Y P Chen, G ChenZhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 24, 2017
[Clinical effect of 156-week telbivudine sequential therapy in HBeAg-positive chronic hepatitis B patients with suboptimal response to pegylated interferon-α-2a therapy]X D Luo, X P Chen, X F ChenZhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|January 12, 2018
[Optimal treatment regimen for patients with HBeAg-positive chronic hepatitis B after suboptimal response to 24 weeks of Peg-IFN α-2a]X D Luo, X P Chen, X F ChenGenetics and Molecular Research : GMR|November 25, 2015
Effects of Tripterygium wilfordii glycosides on regulatory T cells and Th17 in an IgA nephropathy rat modelF Chen, Y L Ma, H Ding, et al.Journal of Viral Hepatitis|October 31, 2017
Comparison of 208-week sequential therapy with telbivudine and entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24 weeks of Peg-IFNα-2a therapy: An open-labelled, randomized, controlled, "real-life" trialX D Luo, X F Chen, Y Zhou, et al.Journal of Medical Genetics|October 10, 1997
Prenatal diagnosis of de novo proximal interstitial deletion of 14q associated with cebocephalyC P Chen, C C Lee, L F Chen, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 30, 2016
[Efficacy of 104-week sequential therapy with telbivudine or entecavir in HBeAg-positive chronic hepatitis B patients with suboptimal responses to 24-week therapy with pegylated interferon-α-2a]X D Luo, X P Chen, R Chen, et al.Scientific Reports|March 25, 2017
Multimode fiber tip Fabry-Perot cavity for highly sensitive pressure measurementW P Chen, D N Wang, Ben Xu, et al.Pageof 979